Evaluation of bone mineral density and vertebral fracture incidence in a group of kidney transplant recipients

2018 ◽  
Author(s):  
Dilek Gogas Yavuz ◽  
Arzu Kahveci ◽  
Onur Bugdayci ◽  
Serhan Tuglular
Keyword(s):  
Bone Mineral Density ◽  
Vertebral Fracture ◽  
Kidney Transplant ◽  
Bone Mineral ◽  
Fracture Incidence ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Mineral Density ◽  
Vertebral Fracture Incidence

Correlations Between Leptin, Body Composition, Bone Mineral Density, and Bone Metabolism in Kidney Transplant Recipients

2005 ◽  
Vol 37 (5) ◽  
pp. 2151-2153 ◽  
Author(s):  
J. Malyszko ◽  
J.S. Malyszko ◽  
K. Pawlak ◽  
J. Konstantynowicz ◽  
S. Wolczynski ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Body Composition ◽  
Bone Metabolism ◽  
Kidney Transplant ◽  
Bone Mineral ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Mineral Density

scholarly journals Continuing Relief of Pain with Long Term Treatment for Osteoporosis with Intravenous Pamidronate

2018 ◽  
Vol 4 (1) ◽  
pp. 51-58
Author(s):  
Wilson S ◽  
Sharp CA ◽  
Davie MWJ
Keyword(s):  
Bone Mineral Density ◽  
Vertebral Fracture ◽  
Side Effects ◽  
Bone Mineral ◽  
Oral Treatment ◽  
Fracture Incidence ◽  
Mineral Density ◽  
Intravenous Pamidronate ◽  
Vertebral Fracture Incidence

Purpose: Bisphosphonates are valuable in reducing the incidence of fracture. Side effects limit persistence with oral therapy and long term studies of pain relief are difficult to pursue. Intravenous bisphosphonates offer an alternative treatment to oral bisphosphonates and are tolerated over a longer period. The use of Pamidronate, an intravenously administered bisphosphonate, to benefit pain and reduce fracture incidence in the long term has not been extensively investigated. The study aimed to investigate the effect of Pamidronate on pain, vertebral fracture incidence and Bone Mineral Density over 6 or more years.Methods: Patients were offered intravenous Pamidronate if oral treatment with bisphosphonates or Hormone replacement therapy had failed due to side effects, fractures continued on oral treatment or oesophageal reflux led to cessation of oral treatment. Pain was assessed using the Nottingham health profile; radiographs were used to evaluate vertebral fracture and DXA measured bone mineral density.Results: The primary outcome was the pain domain. Median patient follow up was 9 years. Pain had improved significantly (p = 0.03) and in 68% pain had either improved or remained unchanged. Vertebral fractures occurred in 14% of patients in the first 3 years, 9.5% in years 4-6, but increased in years 7-9 to 27%. Bone mineral density increased in the lumbar spine (p < 0.001) but not at the femoral neck.Conclusions: Pamidronate had a beneficial effect on pain over the period of the study. Vertebral fracture incidence increased after 6 years of Pamidronate, although spine BMD increased significantly.

Effects of denosumab on hypercalcemia and bone mineral density loss in kidney transplant recipients

2019 ◽  
Vol 92 (1) ◽  
pp. 1-8 ◽  
Author(s):  
Koji Nanmoku ◽  
Takahiro Shinzato ◽  
Taro Kubo ◽  
Toshihiro Shimizu ◽  
Takashi Yagisawa
Keyword(s):  
Bone Mineral Density ◽  
Kidney Transplant ◽  
Bone Mineral ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Mineral Density ◽  
Bone Mineral Density Loss

FP734LOW BONE MINERAL DENSITY PREDICTS FRACTURE IN KIDNEY TRANSPLANT RECIPIENTS

2018 ◽  
Vol 33 (suppl_1) ◽  
pp. i293-i293
Author(s):  
Hanne Skou Jørgensen ◽  
Ivar Eide ◽  
Jens Bollerslev ◽  
Kristin Godang ◽  
Karsten Midtvedt ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Kidney Transplant ◽  
Bone Mineral ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Mineral Density

scholarly journals Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients

2019 ◽  
Vol 95 (6) ◽  
pp. 1461-1470 ◽  
Author(s):  
Pieter Evenepoel ◽  
Kathleen Claes ◽  
Bjorn Meijers ◽  
Michaël R. Laurent ◽  
Bert Bammens ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Turnover ◽  
Kidney Transplant ◽  
Bone Mineral ◽  
Bone Turnover Markers ◽  
De Novo ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Mineral Density ◽  
Turnover Markers

scholarly journals Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients

2010 ◽  
Vol 25 (2) ◽  
pp. E113-E123 ◽  
Author(s):  
Steven W. Ing ◽  
Loraine T. Sinnott ◽  
Sirisha Donepudi ◽  
Elizabeth A. Davies ◽  
Ronald P. Pelletier ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Kidney Transplant ◽  
Bone Mineral ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Mineral Density ◽  
One Year

Changes in Bone Mineral Density, Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 in Kidney Transplant Recipients

Nephron ◽  
2002 ◽  
Vol 91 (3) ◽  
pp. 468-473 ◽  
Author(s):  
Oguz Söylemezoglu ◽  
Ulver Derici ◽  
Turgay Arinsoy ◽  
Alev Hasanoglu ◽  
Ozan Ozkaya ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Growth Factor ◽  
Kidney Transplant ◽  
Bone Mineral ◽  
Binding Protein ◽  
Insulin Like Growth Factor ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients ◽  
Mineral Density ◽  
Factor Binding
Sign in / Sign up

Export Citation Format

Share Document